Immunogenicity Reactogenicity and Breakthrough infection after booster dose with AZD1222 via intradermal route among adult who had received CoronaVac

Ratchadaphisek Sompoch Research Fund0 个研究点目标入组 100 人开始时间: 2021年8月17日最近更新: 2024年8月19日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方
入组人数: 100

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

ow-dose ID AZD1222 booster enhanced lower neutralizing antibodies at 3 months compared with IM route. Less systemic reactogenicity occurred, but higher local reactogenicity.

研究设计

研究类型: Observational

入排标准

年龄范围: 18 Years 至 59 Years（—）
性别: All

入选标准

•1.Thai, age 18-59, 2.Have a history of reciving two dose of CoronaVac vaccine with 14-35 days apart, 3.Post-second dose of CoronaVac vaccine for more than 60-180 days on day of participation in the study.

排除标准

•1.Have a history of COVID-19 infection, 2.Recieved immunosuppressants within 3 months prior to participant in the study, 3.Recieved blood or blood products within 3 months prior to participant in the study

研究者

发起方

Ratchadaphisek Sompoch Research Fund

相似试验

进行中（未招募）

不适用

To understand the effect of additional dose of Covid vaccine in autoimmune double dose vaccinated patients who had covid infection and those who did not have covid infectio

CTRI/2022/05/042572Centre for Arthritis and Rheumatism Excellence CARE

已完成

3 期

Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in AdultsCOVID-19SARS-CoV-2

NCT04516746AstraZeneca32,450

已完成

1 期

Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime-Boost Regimen for the Prevention of COVID-19COVID-19

NCT04684446R-Pharm100

已完成

3 期

The effect of adding IMOD Iranian drug in HIV-positive patientsAIDS.Human immunodeficiency virus [HIV] diseaseB20-B24

IRCT2015070423046N1Vice chancellor for research Of Qom Branch Of Islamic Azad University - Counseling Center for Behavi60

进行中（未招募）

不适用

Safety and efficay of 3 new low dose polio vaccines with adjuvant compared to a full dose polio vaccine without adjuvantProfylactic immunisation against poliomyelitisMedDRA version: 17.0Level: LLTClassification code 10054187Term: Polio immunizationSystem Organ Class: 100000004865

EUCTR2014-000052-29-DKStatens Serum Institut